3-Year Manhunt Ends as Key Figure in ₹25 Crore Fake Cancer Drug Syndicate Captured
In a significant breakthrough, Delhi Police have apprehended Sabir Alam, a central figure in a ₹25 crore counterfeit cancer drug operation, after a relentless three-year pursuit. Alam was arrested on May 20 in Bardhaman, West Bengal, while on his honeymoon, following a critical tip-off and extensive surveillance.
The investigation into this illicit network began in November 2022, leading to the arrest of 14 individuals, including two doctors. Authorities uncovered a clandestine manufacturing unit in Sonipat, Haryana, and a warehouse in Tronica City, Uttar Pradesh, where counterfeit medications were produced and stored. The syndicate’s modus operandi involved refilling empty vials of expensive cancer drugs with inexpensive substances like antifungal agents and selling them at exorbitant prices ranging from ₹1 lakh to ₹3 lakh per vial.
Alam played a pivotal role in distributing these fake medications in Kolkata and coordinating shipments to Bangladesh, where they were supplied to an associate identified as Dr. Rasel. He also managed financial transactions, collecting payments from unsuspecting patients and transferring proceeds to co-conspirators after retaining his share.
Following the arrest of his associates, Alam went into hiding, maintaining a low profile. His capture marks a significant milestone in dismantling the counterfeit drug network that jeopardized the lives of countless cancer patients.
2026-08-31
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Honeywell Acquires Johnson Matthey Catalyst Business at a Discount, Cutting £475 Million from the Price
-
Hormuz Closes, Paint Feels It First: How a Barrel of Oil Rewrites the Cost of Every Barrel of Coatings
-
Sherwin-Williams Opens High-Performance Industrial Coatings Facility in Saskatchewan
-
Oil-Coal Price Gap Widens! Coal Chemical Enterprises See Significant Profit Surge in H1 2026
-
German Chemical Industry Output Slumps to Lowest Utilization Rate Since 1991
-
FDA Dye Phase-Out Push Opens a Bigger Window for Natural Color Solutions
-
EU Chemical Antidumping Complaints Hit a Record High: Trade Remedies Reshape Export Competition
-
New York’s Additive Ban Signals a Tougher Era for Food Formulation
-
Kemira to Acquire SIDRA Wasserchemie, Expanding European Water Treatment Footprint
-
Glyphosate Faces New UK Pressure as EU Trade Alignment Returns to the Debate
Recommend Reading
-
Amazon Turns Lilly’s Weight-Loss Pill Into a Retail Logistics Play
-
U.S. 10% Temporary Tariff Expires, New Section 301 Tariffs Not Yet Implemented
-
DKSH to Distribute Point Grey’s Baby and Personal Care Portfolio in Vietnam
-
New Titanium Dioxide Alternative Moves Closer to Market
-
Lilly Bets Bigger on China
-
September Petrochemical Prices for Gasoline and Diesel Mostly Fluctuate
-
Weak Downward Trend in China's Soda Ash Market in September
-
September Methanol Market Trends Narrowly Consolidate
-
Local Supply Reduction Leads to Significant Increase in Acrylonitrile Prices
-
China's Phenol Market in September Rises First Then Falls